Your browser doesn't support javascript.
loading
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.
Christian, Sonia; Arain, Saad; Patel, Pritesh; Khan, Irum; Calip, Gregory S; Agrawal, Vaibhav; Sweiss, Karen; Griffin, Shawn; Cahill, Kirk; Konig, Heiko; Esen, Aysenur; Shergill, Ardaman; Odenike, Olatoyosi; Stock, Wendy; Quigley, John G.
Affiliation
  • Christian S; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Arain S; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Patel P; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Khan I; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Calip GS; Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Agrawal V; Division of Hematology/Oncology, Department of Medicine, Simon Cancer Center, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, USA.
  • Sweiss K; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Griffin S; Department of Pharmacy; Bone Marrow and Blood Stem Cell Transplantation Program, Indiana University Health, Indianapolis, Indiana, USA.
  • Cahill K; Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Konig H; Division of Hematology/Oncology, Department of Medicine, Simon Cancer Center, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, USA.
  • Esen A; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Shergill A; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Odenike O; Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Stock W; Division of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Quigley JG; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Am J Hematol ; 95(8): 937-943, 2020 08.
Article in En | MEDLINE | ID: mdl-32311140
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Mitoxantrone / Cytarabine / Etoposide Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Mitoxantrone / Cytarabine / Etoposide Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2020 Type: Article Affiliation country: United States